Neuropore is a California-based biopharmaceutical company that develops novel therapeutics for the treatment of neurodegenerative disorders... Read more
Neuropore is a California-based biopharmaceutical company that develops novel therapeutics for the treatment of neurodegenerative disorders... Read more
News
Apr 19, 2022
FirstWord Pharma
Neuropore Therapies: Neuropore Therapies Awarded $4.8M Grant from The Michael J. Fox Foundation for Parkinson's Research to Support Development of Its TLR2 Program
May 17, 2021
socalTECH
Neuropore: Neuropore Therapeutics Gets $20M Milestone Payment
Sep 29, 2020
Business Wire
Press Release: Neuropore : Neuropore Therapies Licenses Autophagy Modulators to Global Cancer Technology for Treatment of Cancers and Other Life-Threatening Diseases
Feb 17, 2020
BioPortfolio
Neuropore: Neuropore Therapies Receives $500000 Grant from The ALS Association to Explore ALS Treatments that Inhibit Neuronal Damage from DiseaseRelated Inflammation
Feb 10, 2020
Pharmabiz
Neuropore: Neuropore chooses INTEGRA Biosciences' Evolve, Viaflo & Voyager pipettes to speed up research
Jan 13, 2020
MarketScreener
Neuropore: Neuropore Completes Phase 1 Clinical Trial in Healthy Volunteers with NPT520-34, a Therapeutic Candidate Aimed at Treating Parkinson's Disease and Amyotrophic Lateral Sclerosis
Oct 29, 2019
MarketScreener
Neuropore: Neuropore Therapies, Inc. : Appoints Dr. Joseph S. McCracken to Board of Directors
Aug 14, 2019
BioPortfolio
Neuropore: Neuropore Receives Orphan Drug Designation for NPT52034 for the Treatment of Amyotrophic Lateral Sclerosis
Aug 05, 2019
firstwordpharma
Neuropore: Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
May 28, 2019
BioPortfolio
Neuropore: UCB Initiates Phase 1b USBased Multicenter Clinical Trial in Parkinsons Disease Patients with UCB0599 a Compound Arising from the NeuroporeUCB Collaboration
Neuropore Therapies Competitors
1
2
3
4
5
6
7
8
9
10